BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25482943)

  • 1. Grade 4 unclassified renal cell carcinoma with sarcomatoid component expressing S-100 protein. A case report with peculiar diagnostic and therapeutic implications.
    Miolo G; Ash A; Buonadonna A; Lo Re G; Torrisi E; Cervo S; Santeufemia DA; Tuzi A; Canzonieri V
    Cancer Biol Ther; 2014; 15(11):1439-43. PubMed ID: 25482943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings.
    Gama A; Xu H; Yang XJ; Choy B
    Int J Surg Pathol; 2024 Feb; 32(1):11-16. PubMed ID: 37063043
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcomes of Patients With Advanced Renal Cell Carcinoma With Non-Clear Cell Histology Treated With Systemic Therapy.
    Urman D; Deshler L; Weise N; Shabaik A; Derweesh I; Bagrodia A; Rose B; Herchenhorn D; McKay RR
    Clin Genitourin Cancer; 2023 Dec; 21(6):660-668.e1. PubMed ID: 37858374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lingual metastasis as an initial presentation of renal cell carcinoma: a case report.
    Raiss H; Duplomb S; Tartas S; Layachi M; Errihani H
    J Med Case Rep; 2017 Nov; 11(1):314. PubMed ID: 29110685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Utility of EMA, Vimentin and CD117 Immunohistochemical Markers in Subtyping Renal Cell Carcinoma in a Nigerian Tertiary Hospital: A 10-year Retrospective Study.
    Nwadiokwu JI; Adegoke OO; Ajani MA; Okolo CA; Awosusi BL; Okebalama VC
    West Afr J Med; 2023 Oct; 40(10):1035-1040. PubMed ID: 37906498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of sarcomatoid differentiation in renal cell carcinoma by machine learning on multiparametric MRI.
    Mazin A; Hawkins SH; Stringfield O; Dhillon J; Manley BJ; Jeong DK; Raghunand N
    Sci Rep; 2021 Feb; 11(1):3785. PubMed ID: 33589715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spindle Cell Renal Neoplasms: A Pathological Case Report on Primary Renal Leiomyosarcoma and Sarcomatoid Renal Cell Carcinoma.
    Popov H; Petkova L; Stoyanov GS
    Cureus; 2023 Oct; 15(10):e46449. PubMed ID: 37927619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stratification of Patients with Renal Cell Carcinoma by the Abundance of Sarcomatoid Features Reveals Differences in Survival and the Underlying Pathobiology.
    Salgia NJ; Aubrecht WM; Wang L; Ram B; Wasik BJ; Khan A; Attwood K; Daza J; Long MD; Eng KH; Xu B; Muhitch JB; Kauffman EC
    Eur Urol Oncol; 2024 Mar; ():. PubMed ID: 38480032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcomatoid and Rhabdoid Renal Cell Carcinoma: Clinical, Pathologic, and Molecular Genetic Features.
    Adeniran AJ; Shuch B; Humphrey PA
    Am J Surg Pathol; 2024 May; ():. PubMed ID: 38736105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonfamilial Bilateral Synchronous Renal Cell Carcinoma with Discordant Histology with Eventual Complete Response to Dual Immunotherapy.
    Robertson IJ; Grigsby SM; Mattingly JC; Park DK
    Case Rep Oncol; 2023; 16(1):1378-1383. PubMed ID: 37965647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful mammalian target of rapamycin inhibitor maintenance therapy following induction chemotherapy with gemcitabine and doxorubicin for metastatic sarcomatoid renal cell carcinoma.
    Numakura K; Tsuchiya N; Akihama S; Inoue T; Narita S; Huang M; Satoh S; Habuchi T
    Oncol Lett; 2014 Jul; 8(1):464-466. PubMed ID: 24959297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-targeted tyrosine kinase inhibitor reverses resistance to immunotherapy in hepatic sarcomatoid carcinoma.
    Chen J; Chen W; Qu X; Chen Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17849-17853. PubMed ID: 37943357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcomatoid Dedifferentiation in Renal Cell Carcinoma: From Novel Molecular Insights to New Clinical Opportunities.
    Debien V; Thouvenin J; Lindner V; Barthélémy P; Lang H; Flippot R; Malouf GG
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31906050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Leiomyosarcoma: Unraveling the Mysteries of a Rare Malignancy.
    Poombal F; Ahsan M; Noor R; Nasir S; Khan A
    Cureus; 2023 Sep; 15(9):e45476. PubMed ID: 37859906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vulvar Sarcomatoid Squamous Cell Carcinoma: A Rare Entity.
    Gund G; Chadha A; Dongre A; Nayak C
    Indian Dermatol Online J; 2023; 14(6):856-860. PubMed ID: 38099028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Histone H3K27 Trimethylation (H3K27me3) Expression as a Potential Diagnostic Pitfall in Sarcomatoid Carcinoma.
    Zilla ML; John I; Naous R
    Int J Surg Pathol; 2023 Nov; ():10668969231215819. PubMed ID: 37997394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcomatoid renal pelvis carcinoma: Experience of treatment at a single-institution.
    Liu T; Yao Y; Geng C; Guan F; Zhang G
    Eur J Surg Oncol; 2024 Mar; 50(6):108251. PubMed ID: 38492258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery after combination therapy with a tyrosine kinase inhibitor and anti-PD-1 antibody in sarcomatoid hepatocellular carcinoma: case report and literature review.
    Liang B; Huang T; Kuang SL; Xie GY; Liu TQ; Chen YY
    Front Oncol; 2023; 13():1212013. PubMed ID: 37869099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal pelvis sarcomatoid carcinoma with renal vein tumor thrombus: A case report and literature review.
    Guan HY; Wang J; Wang JX; Chen QH; Lu J; He L
    World J Clin Cases; 2023 Nov; 11(31):7690-7698. PubMed ID: 38078137
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.